Behavior and Behavior Mechanisms, Influenza
Conditions
Keywords
Influenza, Vaccination, Nudging, Behavioral Science
Brief summary
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. This study will investigate investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among eligible influenza vaccination candidates.
Detailed description
The study is a prospective, randomized, open-label implementation trial. The study population will consist of persons identified as eligible for free-of-charge influenza vaccination in the Danish health system aged 18 years and above. Subjects will be identified through Danish nationwide health registries using codes from the International Classification of Diseases, 10th revision (ICD-10) and the Anatomical Therapeutic Chemical (ATC) classification system. Individuals will be randomized to 1 of 10 arms (1 control arm and 9 intervention arms) with each testing different nudging strategies employing various behavioural economic principles. The interventions will be delivered through the official, mandatory Danish electronic letter system. All subject data will be retrieved from the Danish nationwide registries with the exception of information on intervention allocation. Endpoints will be retrieved at prespecified dates using prespecified search algorithms. The study will be performed in collaboration with the Danish Health Data Authority and Statens Serum Institut.
Interventions
The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Age \>=65 years at January 15, 2023 (eligible for free influenza vaccination in the official Danish vaccination program) 2. Access to the official, mandatory Danish electronic mailbox system
Exclusion criteria
1\) Persons living in nursing homes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of participants who received an influenza vaccine | Up to 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Time from intervention delivery to influenza vaccination | Up to 3 months |
Other
| Measure | Time frame |
|---|---|
| Number of participants with any hospitalization | Up to 8 months |
| All-cause mortality | Up to 8 months |
| Composite of incident heart failure, heart failure hospitalization, or cardiovascular death | Up to 8 months |
| Composite of myocardial infarction, stroke, or cardiovascular death | Up to 8 months |
| Composite of myocardial infarction, coronary revascularization, stroke, or cardiovascular death | Up to 8 months |
| Number of participants with incident heart failure or heart failure hospitalization | Up to 8 months |
| Cardiovascular death | Up to 8 months |
| Number of participants with laboratory-confirmed influenza | Up to 8 months |
| Number of participants with coronary revascularization | Up to 8 months |
| Number of participants with stroke | Up to 8 months |
| Number of contacts to general practitioner (excluding vaccination visit) | Up to 8 months |
| Number of participants with laboratory-confirmed COVID-19 | Up to 8 months |
| Number of participants with a hospitalization due to COVID-19 | Up to 8 months |
| Number of participants who received a COVID-19 vaccine | Up to 3 months |
| Number of participants with myocardial infarction | Up to 8 months |
| Number of participants with a hospitalization with influenza or pneumonia | Up to 8 months |
Countries
Denmark